SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Pharma informs about sustainability report

08 Sep 2023 Evaluate
Piramal Pharma has informed that it enclosed a Sustainability Report of the Company for the financial year 2022-23. The said information is also available on the website of the Company at www.piramal.com

The above information is a part of company’s filings submitted to BSE.

Piramal Pharma Share Price

176.85 -7.20 (-3.91%)
12-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1845.90
Dr. Reddys Lab 1270.10
Cipla 1292.00
Zydus Lifesciences 930.75
Lupin 2246.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×